FDA

Americans will soon have access to an infusion treatment that provides round-the-clock relief of Parkinson's symptoms. The US FDA has green-lit this innovative drug delivery system, which is expected to be available in the fourth quarter of 2025.

HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found promise in permanently eliminating the virus, thanks to a drug already approved by the FDA to fight cancer.

The US Food and Drug Administration has approved the use of a novel painkiller for short-term moderate-to-severe pain in adults. It’s the first of a new class of analgesics to be approved in over 20 years - and, importantly, isn't addictive.

Take control of your food and water safety with the first-of-its-kind EcoTracker, a user-friendly pocket-sized device that almost instantly assesses contaminants in fruits, vegetables and meats, as well as the quality of your drinking water.

After the FDA proposed pulling some cold and flu medications from shelves in the US, an Australian law firm has launched a class action against Johnson & Johnson, claiming that it has knowingly marketed and sold ineffective decongestants for years.

In a much-needed update to 2003 data on attention-deficit/hyperactivity disorder in the US, a new report has found that 15.5 million American adults have been diagnosed with the condition – and many have been let down by poor access to treatment.

A pioneering once-a-day pill that regenerates nerve cell connections damaged by ALS has been FDA-approved for ongoing clinical trials. The drug is now being given to those with ALS and could be a watershed moment in the treatment of the fatal disease.

A drug used to treat asthma has been shown to substantially reduce the risk of potentially life-threatening reactions in people aged one and older with multiple common food allergies, including peanuts, following accidental exposure.

The FDA has granted clearance to the first AI-powered medical device to assist physicians in detecting all 3 common skin cancers. Providing a more accurate way of identifying skin cancer will enable patients to access necessary treatment more quickly.

The FDA has approved the first cell-based gene therapies for treating sickle cell disease, one of which is the first approved therapy to utilize the CRISPR/Cas9 gene editing technology. It signals advancements in gene therapy and regenerative medicine.

The US has officially got a homegrown hero in the burgeoning global industry of effective weight-loss treatment, with the FDA approval of Lilly’s Zepbound. The company has revealed its cost, dosages, insurance subsidies and when it will be on shelves.

With an industry expected to be worth US$100 billion by 2030, a supply crisis, slow manufacturing processes, and a high price tag, it's no surprise the much-hyped class of injectable weight-loss drugs has become a prime target for counterfeit trade.